In this issue:

  • Conducting HIV vaccine trials around the world: What we've learned so far
  • A long, rocky path: an interview with Uganda's Roy Mugerwa
  • From "guinea pig" fears to Phase II trials
  • Studying the volunteers
  • The ebbs and flows of AIDS vaccine trials
  • ALVAC Prime Boost Trial Results Announced
  • PMC's Canarypox Vectors
  • Viewpoint: Do HIV Clades Really Matter?
  • AIDS Vaccine Glossary
  • Vaccine Briefs